Cilengitide (EMD 121974) (IND 59073) in Recurrent or Progressive and Refractory Childhood High-Grade Glioma.

Trial Profile

Cilengitide (EMD 121974) (IND 59073) in Recurrent or Progressive and Refractory Childhood High-Grade Glioma.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Jul 2014

At a glance

  • Drugs Cilengitide (Primary)
  • Indications Anaplastic astrocytoma; Glioblastoma; Glioma; Gliosarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Jul 2013 Status changed from suspended to completed as reported by ClinicalTrials.gov.
    • 24 Jul 2013 Status changed from suspended to completed as reported by ClinicalTrials.gov.
    • 13 Nov 2012 Status changed from completed to suspended as reported by ClinicalTrials.gov (NCT00679354).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top